MBX
MBX Biosciences, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$61.72
+0.49%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.12x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.47x
Liquidity & coverage
- Current ratio
- 18.08x
- Quick ratio
- 18.08x
- Cash ratio
- 17.69x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $404.2M
Cash & dividend
- FCF / debt
- -25.50x
- Cash flow / debt
- -24.74x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026